Xenogeneic extracellular matrix as a scaffold for tissue reconstruction

Transplant Immunology

Volumn 12, Issue 3-4, 2004, Pages 367-377

  Badylak, Stephen F ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Bioscaffold; Extracellular matrix; Immune response; Regenerative medicine; Small intestinal submucosa (SIS); Tissue engineering; Urinary bladder matrix (UBM); Xenogeneic scaffold

Indexed keywords

COLLAGEN; CYTOKINE; FIBRONECTIN; GLYCOSAMINOGLYCAN; GROWTH FACTOR; LAMININ;

ARTERY GRAFT; BLADDER; EXTRACELLULAR MATRIX; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INSTRUMENT STERILIZATION; MOLECULE; NONHUMAN; ORGANIZATION; PLASTIC SURGERY; PRIORITY JOURNAL; REVIEW; SAFETY; SCAR; SMALL INTESTINE; SWINE; TISSUE ENGINEERING; TISSUE STRUCTURE; URETHRA; XENOGRAFT;

EID: 2442425309     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2003.12.016     Document Type: Article

References (126)

1. Bissell M.J., Hall H.G., Parry G. How does the extracellular matrix direct gene expression? J Theor Biol. 99:1982;31-68
2. Boudreau N., Myers C., Bissell M.J. From lamini to lamin: regulation of tissue-specific gene expression by the ECM. Trends Cell Biol. 5:1995;1-4
3. Ingber D. Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis. J Cell Biochem. 47:1991;236-241
4. Vanderrest M., Garrone R. Collagen family of proteins. FASEB J. 5:1991;2814-2823
5. Laurie G.W., Horikoshi S., Killen P.D., Degui-Real B., Yamada Y. In situ hybridization reveals temporal and spatial changes in cellular expression of mRNA for a laminin receptor, laminin and basement membrane (type IV) collagen in the developing kidney. J Cell Biol. 109:1989;1351-1362
6. Martins-Green M., Bissel M.F. Cell-extracellular matrix interactions in development. Semin Dev Biol. 6:1995;149-159
7. Baldwin H.S. Early embryonic development. Cardiovasc Res. 31:1996;E34-E45
8. Barnard K., Gathercole L.J. Short and long range order in basement membrane type IV collagen revealed by enzymatic and chemical extraction. Int J Biol Macromol. 13:1991;359-365
9. Piez K.A. Molecular and aggregate structures of the collagens. Piez K.A., Reddi A.H. Extracellular Matrix Biochemistry. 1984;1-39 Elsevier, New York
10. Yurchenco P.D., Birk D.E., Mecham R.P. Extracellular Matrix Assembly and Structure. 1994;1 Academic Press
11. Schwarzbauer J.E. Fibronectin: from gene to protein. Curr Opin Cell Biol. 3:1991;786-791
12. Miyamoto S., Katz B.Z., Lafrenie R.M., Yamada K.M. Fibronectin and integrins in cell adhesion, signaling and morphogenesis. Ann NY Acad Sci. 857:1998;119-129
13. Schwarzbauer J.E. Basement membranes: putting up the barriers. Curr Biol. 9:1999;R242-R244
14. McPherson T.B., Badylak S.F. Characterization of fibronectin derived from porcine small intestinal submucosa. Tissue Eng. 4:1998;75-83
15. Li S., Harrison D., Carbonetto S., Fassler R., Smyth N., Edgar D., et al. Matrix assembly, regulation and survival functions of laminin and its receptors in embryonic stem cell differentiation. J Cell Biol. 157:2002;1279-1290
16. Timpl R. Macromolecular organization of basement membranes. Curr Opin Cell Biol. 8:1996;618-624
17. Timpl R., Brown J. Supramolecular assembly of basement membranes. BioEssays. 18:1996;123-132
18. Ponce M., Nomizu M., Delgado M.C., Kuratomi Y., Hoffman M.P., Powell S., et al. Identification of endothelial cell binding sites on the laminin gamma-1 chain. Circ Res. 84:1999;688-694
19. Werb Z., Cu T.H., Rinkenberger J.L., Coussens L.M. Matrix-degrading proteases and angiogenesis during development and tumor formation. Acta Pathol Microbiol Immunol Scand. 107:1999;11-18
20. Ponce M., Nomizu M., Delgado M.C., Kuratomi Y., Hoffman M.P., Powell S., et al. Identification of endothelial cell binding sites on the laminin gamma-1 chain. Circ Res. 84:1999;688-694
21. Werb Z., Cu T.H., Rinkenberger J.L., Coussens L.M. Matrix-degrading proteases and angiogenesis during development and tumor formation. Apmis. 107:1999;11-18
22. Entwistle J., Zhang S., Yang B., et al. Characterization of the murine gene encoding the hyaluronan receptor RHAMM. Gene. 163:(2):October 3 1995;233-238
23. Hodde J.P., Badylak S.F., Brightman A.O., Voytik-Harbin S.L. Glycosaminoglycan content of small intestinal submucosa: a bioscaffold for tissue replacement. Tissue Eng. 2:1996;209-217
24. Bonewald L.F. Regulation and regulatory activities of transforming growth factor beta. Crit Rev Eukaryotic Gene Expr. 9:1999;33-44
25. Kagami S., Kondo S., Loster K., Reutter W., Urushihara M., Kitamura A., et al. Collagen type I modulates the platelet-derived growth factor (PDGF) regulation of the growth and expression of beta 1 integrins by rat mesangial cells. Biochem Biophys Res Commun. 252:1998;728-732
26. Roberts R., Gallagher J., Spooncer E., Allen T.D., Bloomfield F., Dexter T.M. Heparan sulfate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature (London). 332:1988;376-378
27. Badylak S.F., Lantz G., Coffey A., Geddes L.A. Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res. 47:1989;74-80
28. Lantz G., Badylak S.F., Coffey A., Geddes L.A., Blevins W.E. Small intestinal submucosa as a small diameter arterial autograft in the dog. J Invest Surg. 3:1990;1097-1103
29. Sandusky G.E., Badylak S.F., Morff R.J., Johnson W.D., Lantz G. Histologic findings after in-vivo placement of small intestine submucosal vascular grafts and saphenous vein grafts in the carotid artery in dogs. Am J Pathol. 140:1992;317-324
30. Sandusky G.E., Lantz G.C., Badylak S.F. Healing comparison of small intestine submucosa and ePTFE grafts in the canine carotid artery. J Surg Res. 58:1995;415-420
31. Lantz G.D., Badylak S.F., Sandusky G.E., Hiles M.C., Coffey A.C., Geddes L.A., et al. Small intestinal submucosa as a vascular graft: a review. J Invest Surg. 6:1993;297-310
32. Badylak S.F., Voytik S.L., Kokini K., Shelbourne K.D., Klootwyk T., Kraine M.R., et al. The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model. J Biomed Mater Res. 29:1995;977-985
33. Kropp B.P. Small intestinal submucosa for bladder augmentation: a review of preclinical studies. World J Urol. 16:1998;262-267
34. Robotin-Johnson M.C., Swanson P.E., Johnson D.C., Schuessler R.B., Cox J.L. An experimental model of small intestinal submucosa as a growing vascular graft. J Thorac Cardiovasc Surg. 116:1998;805-811
35. Cook J.L., Tomlinson J.L., Kreeger J.M., Cook C.R. Induction of meniscal regeneration in dogs using a novel biomaterial. Am J Sports Med. 27:1999;658-665
36. Dalla Vecchia L., Engum S., Kogon B., Jensen E., Davis M., Grosfeld J. Evaluation of small intestine submucosa and acellular dermis as diaphragmatic prostheses. J Pediatr Surg. 34:1999;167-171
37. Billiar K., Murray J., Laude D., Abraham G., Bachrach N. Effects of carbodiimide crosslinking conditions on the physical properties of laminated intestinal submucosa. J Biomed Mater Res. 56:(1):2001 July;101-108
38. Cook J.L., Tomlinson J.L., Arnoczky S.P., Fox D.B., Cook C.R., Kreeger J.M. Kinetic study of the replacement of porcine small intestineal submucosal grafts and the regeneration of meniscal-like tissue in avascular meniscal defects in dogs. Tissue Eng. 7:(3):2001 June;321-324
39. Dejardin L.M., Arnoczky S.P., Ewers B.J., Haut R.C., Clarke, Rhonda. Tissue-engineered rotator cuff tendon using porcine small intestinal submucosa. Histologic and mechanical evaluation in dogs. Am J Sports Med. 29:(2):2001;175-184
40. Atala A., Guzman L., Retik A.B. A novel inert collagen matrix for hypospadias repair. J Urol. 162:1999;1148-1151
41. Badylak S.F., Meurling S., Chen M., Spievack A., Simmons-Byrd A. Resourcable bioscaffold for esophageal repair in a dog model. J Pediatr Surg. 35:(7):2000;1003-1097
42. Huber J.E., Spievack A., Simmons-Byrd A., Ringel R.L., Badylak S.F. Extracellular matrix as a scaffold for laryngeal reconstruction. Ann Otol Rhinol Laryngol. 112:(5):2003;428-433
43. Prevel D.C., Eppley B.L., Summerlin D.J., Jackson J.R., McCarty M., Badylak S.F. Small intestinal submucosa (SIS): utilization as a wound dressing in full-thickness rodent wounds. Ann Plast Surg. 35:1995;381-388
44. Badylak S.F., Record R., Lindberg K., Hodde J., Park K. Small intestinal submucosa: a substrate for in vitro cell growth. J Biomater Sci. 9:1998;863-878
45. Lindberg K., Badylak S.F. Porcine small intestinal submucosa (SIS): a bioscaffold supporting in vitro primary human epidermal cell differentiation and synthesis of basement membrane proteins. Burns. 27:2001;254-266
46. Badylak S.F. The extracellular matrix as a scaffold for tissue reconstruction. Semin Dev Cell Biol. 13:(5):2002;377-383
47. Badylak S.F., Coffey A.C., Lantz G.C., Tacker W.A., Geddes L.A. Comparison of the resistance to infection of intestinal submucosa arterial autografts vs. polytetrafluoroethylene arterial prostheses in a dog model. J Vasc Sur. 1994 March;465-472
48. Niklason L.E., Abbott W., Gao J., Klagges B., Hirschi K.K., Ulubayram K., et al. Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg. 33:(3):March 2001;628-638
49. L'Heureux N., Paquet S., Labbe R., Germain L., Auger F.A. A completely biological tissue-engineered human blood vessel. FASEB J. 12:(1):1998 January;47-56
50. L'Heureux N., Germain L., Labbe R., Auger F.A. In vitro construction of a human blood vessel from cultured vascular cells: morphologic study. J Vasc Surg. 17:(3):1993 March;499-509
51. Mitchell S.L., Niklason L.E. Requirements for growing tissue-engineered vascular grafts. Cardiovasc Pathol. 12:(2):March-April 2003;59-64
52. Prabhaker V., Grinstaff M.W., Alarcon J., Knors C., Solan A.K., Niklason L.E. Engineering porcine arteries: effects of scaffold modification. J Biomed Mater Res A. 67:(1):2003 October 1;303-311
53. Niklason L.E. Total tissue engineered vascular grafts. Atherosclerosis. 151:(1):July 2000;93
54. Niklason L.E., Langer R.S. Advances in tissue engineering of blood vessels and other tissues. Transplant Immunol. 5:(4):December 1997;303-306
55. Solan A., Prabhakar V., Niklason L. Engineered vessels: importance of the extracellular matrix. Transplant Proc. 33:(1-2):February-March 2001;66-68
56. Lantz G.C., Badylak S.F., Coffey A.C., Geddes L.A., Sandusky G.E. Small intestinal submucosa as a superior vena cava graft in the dog. J Surg Res. 53:1992;175-181
57. Pavcnik D., Uchida B.T., Timmermans H.A., Corless C.L., O'Hara M., Toyota N., et al. Percutaneous bioprosthetic venous valve: a long-term study in sheep. J Vasc Surg. 35:(3):2002 March;598-602
58. Pavcnik D., Uchida B., Timmermans H., Keller F.S., Rosch J. Square stent: a new self-expandable endoluminal device and its applications. Cardiovasc Intervent Radiol. 24:2001;207-217
59. Piechota H.J., Gleason C.A., Dahms S.E., Dahiya R., Nunes L.S., Lue T.F., et al. Bladder acellular matrix graft: in vivo functional properties of the regenerated rat bladder. Urol Res. 27:1999;206-213
60. Piechota H.J., Dahms S.E., Probst M., Gleason C.A., Nunes L.S., Dahiya R., et al. Functional rat bladder regeneration through xenotransplantation of the bladder acellular matrix graft. Br J Urol. 81:1998;548-559
61. Dahms S.E., Piechota H.J., Dahiya R., Lue T.F., Tanagho E.A. Composition and biomechanical properties of the bladder acellular matrix graft: comparative analysis in rat, pig and human. Br J Urol. 82:1998;411-419
62. Dahms S.E., Piechota H.J., Nunes L., Dahiya R., Lue T.F., Tanagho E.A. Free ureteral replacement in rates: regeneration of ureteral wall components in the acellular matrix graft. Urology. 50:1997;818-825
63. Atala A., Guzman L., Retik A.B. A novel inert collagen matrix for hypospadias repair. J Urol. 162:1999;11 148-11 151
64. Yoo J.J., Meng J., Oberpenning F., Atala A. Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology. 51:1998;221-225
65. Rickey F.A., Elmore D., Hillegonds D., Badylak S.F., Record R., Simmons-Byrd A. Re-generation of tissue about an animal-based scaffold: ams studies of the fate of the scaffold. Nucl Instrum Methods Phys Res. 172:2000;904-909
66. Record R.D., Hillegonds D., Simmons C., Tullius R., Rickey F.A., Elmore D., et al. In vivo degradation of 14C-labeled small intestinal submucosa (SIS) when used for urinary bladder repair. Biomaterials. 22:2001;2653-2659
67. Kropp B.P., Pope J.C. Small intestinal submucosa: a novel substance for the study of cellular interaction and regeneration in the bladder. Dialogues Pediatr Urol. 20:1997;1-8
68. Pope J.C. 4th, Davis M.M., Smith E.R. Jr, Walsh M.J., Ellison P.K., Rink R.C., et al. The ontogeny of canine small intestinal submucosa regenerated bladder. J Urol. 158:1997;1105-1110
69. Elbahnasy A.M., Shalhav A., Hoenig D.M., Figenshau R., Clayman R.V. Bladder wall substitution with synthetic and non-intestinal organic materials. J Urol. 159:1998;628-637
70. Xie H., Shaffer B.S., Wadia Y., Gregory K.W. Use of reconstructed small intestine submucosa for urinary tract replacement. ASAIO J. 46:2000;268-272
71. Zhang Y., Kropp B.P., Moore P., Cowan R., Furness P.D. 3rd, Kolligan M.E., et al. Coculture of bladder urothelial and smooth muscle cells on small intestinal submucosa: potential applications for tissue engineering technology. J Urol. 164:(3 Pt 2):2000;9928-9934
72. Grossklaus D.J., Shappell S.B., Adams M.C., Brock J.W. III, Pope J.C. IV. Small intestinal submucosa as a urethral coverage layer. J Urol. 166:2001;636-639
73. Jaffe J.S., Ginsburg P.C., Yanoshak S.J., Costa L.E., Ogbolu F.N., Moyer C.P., et al. Ureteral segment replacement using a circumferential small intestinal submucosa xenogenic graft. J Invest Surg. 14:2001;259-265
74. Knoll L.D. Use of porcine small intestinal submucosal graft in the surgical management of tunical deficiencies with penile prosthetic surgery. Urology. 59:(5):2002;758-761
75. Sofer M., Rowe E., Forder D.M., Denstedt J.D. Ureteral segmental replacement using multiplayer porcine small intestinal submucosa. J Endourol. 16:(1):2002 February;27-31
76. Knapp P.M., Lingeman J.E., Siegel Y.I., Badylak S.F., Demeter R.J. Biocompatibility of small intestinal submucosa in urinary tract as augmentation cystoplasty graft and injectable suspension. J Endourol. 8:1994;125-130
77. Kropp B.P., Rippy M.K., Badylak S.F., Adams M.C., Keating M.A., Rink R.C., et al. Regenerative urinary bladder augmentation using small intestinal submucosa: urodynamic and histopathologic assessment in long term canine bladder augmentations. J Urol. 155:1996;2098-2104
78. Kropp B.P., Sawyer B.D., Shannon H.E., Ripy M.K., Badylak S.F., Adams M.C., et al. Characterization of small intestinal submucosa-regenerated canine detrusor: assessment of reinnervation, in vita compliance and contractility. J Urol. 156:1996;599-607
79. Badylak S.F., Kropp B., McPherson T., Liang H., Snyder P.W. SIS: a rapidly resorbable bioscaffold for augmentation cystoplasty in a dog model. Tissue Eng. 4:1998;379-387
80. Michel M., L'Heureux N., Pouliot R., Xu W., Auger F.A., Germain L. Characterization of a new tissue-engineered human skin equivalent with hair. In Vitro Cell Dev Biol Anim. 35:(6):1999 June;318-326
81. Black A.F., Berthod F., L'Heureux N., Germain L., Auger F.A. In vitro reconstruction of a human capillary-like net work in a tissue-engineered skin equivalent. FASEB J. 12:(13):1998 October;1331-1340
82. Michel M., L'Heureux N., Auger F.A., Germain L. From newborn to adult: phenotypic and functional properties of skin equivalent and human skin as a function of donor age. J Cell Physiol. 171:(2):1997 May;179-189
83. Bello Y.M., Falabella A.F., Eaglstein W.H. Tissue-engineered skin:current status in wound healing. Am J Clin Dermatol. 2:(5):2001;305-313
84. Dejardin L.M., Arnoczky S.P., Clarke R.B. Use of small intestinal submucosal implants for regeneration of large fascial defects: an experimental study in dogs. J Biomed Mater Res. 46:1999;203-211
85. Aiken S.W., Badylak S.F., Toombs J.P., Shelbourne K.D., Hiles M.C., Lantz G.C., et al. Small intestinal submucosa as an intra-articular ligamentous repair material: a pilot study in dogs. Vet Comp Orthop Traumatology. 7:1994;124-128
86. Badylak S.F., Arnoczky S., Plouhar P., Haut R., Mendenhall V., Horvath C. Naturally-occurring ECMs as scaffolds for musculoskeletal repair. Clin Orthop Relat Res. 367S:1999;S333-S343
87. Musahl V, Abramowitch S, Gilbert TW, Tsuda E, Wang JHC, Badylak SF, et al. The use of porcine small intestinal submucosa to enhance the healing of the medial collateral ligament - a functional tissue engineering study in rabbits. J Orthop Res (in press)
88. Metcalf M.H., Savoie F.H. III, Kellum B. Surgical Technique for xenograft (SIS) augmentation of rotator-cuff repairs. Oper Tech in Ortho. 12:(3):2002;204-208
89. Badylak SF, Geddes LA, Obermiller J, Matheny R. Extracellular matrix scaffold for myocardial repair. Cardiothorac Surg rum. 2003. www.hsforum.com/vol6/issue2/2002-72222.html
90. Cobb M.A., Badylak S.F., Janas W., Simmons-Byrd A., Boop F.A. Porcine small intestinal submucosa as a dural substitute. Surg Neurol. 51:(1):1999;99-104
91. Cobb M.A., Badylak S.F., Janas W., Boop F.A. Histology after dural drafting with small intestinal submucosa. Surg Neurol. 46:1996;389-394
92. Prevel C.D., Eppley B.L., Summerlin D.J., Jackson J.R., McCarty M., Badylak S.F. Small intestinal submucosa (SIS): utilization for repair of rodent abdominal wall defects. Ann Plast Surg. 35:1995;374-380
93. Badylak S.F., Kokini K., Tullius B., Whitson B. Strength over time of a resorbable bioscaffold for body wall repair in a dog model. J Surg Res. 99:2001;282-287
94. Badylak S.F., Kokini K., Tullius B., Simmons-Byrd A., Morff R. Morphologic study of small intestinal submucosa as a body wall repair device. J Surg Res. 103:2002;190-202
95. Clarke K.M., Lantz G.C., Salisbury S.K., Badylak S.F., Hiles M.C., Voytik S.L. Intestine submucosa and polypropylene mesh for abdominal wall repair in dogs. J Surg Res. 60:1996;107-114
96. Hodde J.P., Badylak S.F., Shelbourne K.D. The effect of range of motion on remodeling of small intestinal submucosa (SIS) when used as an Achilles tendon repair material in the rabbit. Tissue Eng. 3:1997;27-37
97. Suckow M.A., Voytik S.L., Terril L.A., Badylak S.F. Enhanced bone regeneration by porcine small intestinal submucosa. J Invest Surg. 12:1999;277-287
98. Welch J.A., Montgomery R.D., Lenz S.D., Plouhar P., Shelton W.R. Evaluation of small intestinal submucosa implants for repair of meniscal defects in dogs. Am J Vet Res. 63:(3):2002 March;427-431
99. Peel S.F., Chen H., Renlund R., Badylak S.F., Kandel R.A. Formation of a SIS-cartilage composite graft in vitro and its use in the repair of articular cartilage defects. Tissue Eng. 4:1998;143-155
100. Sarikaya A., Record R., Wu C.-C., Tullius B., Badylak S.F., Ladisch M. Antimicrobial activity associated with extracellular matrices. Tissue Eng. 8:(1):2002;63-71
101. Badylak S.F., Park K., Peppas N., McCabe G., Yoder M. Marrow-derived cells populate scaffolds composed of xenogeneic extracellular matrix. Exp Hematol. 29:2001;1310-1318
102. Badylak S.F., Wu C.C., Bible M., McPherson E. Host protection against deliberate bacterial contamination of an extracellular matrix bioscaffold vs. Dacron™ Mesh in a dog model of orthopedic soft tissue repair. J Biomed Mater Res B. 67:2003;648-654
103. Schneider P. Alternative sterilization technologies come of age: peracetic acid. Med Device Technol Ind. December 1992;43-44
104. Block S.S. Disinfectants and antiseptics in disinfection, sterilization and preservation. fourth ed :1991;172-180 Lea and Febiger, Philadelphia, PA
105. McDevitt C.A., Wildey G.M., Cutrone R.M. Transforming growth factor-β1 in a sterilized tissue derived from the pig small intestine submucosa. J Biomed Mater Res A. 67:2003;637-640
106. Galili U. Interaction of the natural anti-Gal antibody with a-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today. 14:1993;480-482
107. Galili U., Rachmilewitz E.A., Peleg A., Flechner I. A unique natural human IgG antibody with anti-a-galactosyl specificity. J Exp Med. 160:1984;1519-1531
108. Good A.H., Cooper D.K.C., Malcom A.J., et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc. 24:1992;559-562
109. Sandrin M.S., Vaughan H.A., Dabkowski P.L., McKenzie I.F.C. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci USA. 90:1993;11 391-11 395
110. Koren E., Kujundzic M., Koscec M., et al. Cytotoxic effects of human preformed anti-Gal IgG and complement on cultured pig cells. Transplant Proc. 26:1994;1336-1339
111. Goldberg L.D., Lee J., Cairns T., et al. Polymorphism within the human anti-pig repertoire. Transplant Proc. 28:1996;549-550
112. Farivar R.S., Filsoufi F., Adams D.H. Mechanisms of Gala1-3Galβ1- 4GicNAc-R (aGal) expression on porcine valve endothelial cells. J Thorac Cardiovasc Surg. February 2003;306-314
113. Schussler O., Shen M., Shen L., Carpentier S.M., Kaveri S., Carpentier A. Effect of human immunoglobulins on the immunogenicity of porcine bioprostheses. Soc Thoracic Surgeons. 2001;S396-S400
114. McPherson T.B., Liang A.H., Record R.D., Badylak S.F. Gala(1, 3)Gal epitope in porcine small intestinal submucosa (SIS). Tissue Eng. 6:(3):2000;233-239
115. Raeder R.H., Badylak S.F., Sheehan C., Kallakury B., Metzger D.W. Natural anti-galactose antibodies delay, but do not prevent, acceptance of extracellular matrix xenografts. Transplant Immunol. 10:2002;17-26
116. Zhai Y., Ghobrial R.M., Busuttil R.W., Kupiec-Weglinski J.W. Th1 and Th2 cytokines in organ transplantation: paradigm lost? Crit Rev Immunol. 19:1999;155
117. Strom T.B., Roy-Chaudhury P., Manfro R. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol. 8:1996;688
118. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787
119. Matsumiya G., Shirakura R., Miyagawa S., Izutani H., Nakata S., Matsuda H. Assessment of T-cell subsets involved in antibody production and cell-mediated cytotoxicity in rat-to-mouse cardiac xenotransplantation. Transplant Proc. 26:1994;1214
120. Chen N., Gao Q., Field E.H. Prevention of Th1 responses is critical for tolerance. Transplantation. 61:1996;1076
121. Piccotti J.R., Chan S.Y., VanBuskirk A.M., Eichwald E.J., Dishop D.K. Are Th2 helper T lymphocytes beneficial, deleterious or irrelevant in promoting allograft survival? Transplantation. 63:1997;619
122. Bach F.H., Ferran C., Hechenleitner P., et al. Accommodation of vascularized xenografts: expression of 'protective genes' by donor epithelial cells in a host Th2 cytokine environment. Nature Med. 3:1997;196
123. Chen N., Filed E.H. Enhanced type 2 and diminished type 1 cytokines in neonatal tolerance. Transplantation. 59:1995;933
124. Allman A.J., McPherson T.B., Badylak S.F., Liang H.A., Swanson B.R., HogenEsch H., et al. Xenogeneic extracellular matrix grafts elicit a Th2-restricted immune response. Transplantation. 17:2001;1631-1640
125. Chen R.H., Adams D.H. Transgenic porcine valves show no signs of delayed cardiac xenograft rejection. Soc Thoracic Surgeons. 2001;S389-S392
126. Moore M.A., Phillips R.E. Biocompatibility and immunologic properties of pericardial tissue stabilized by dye-mediated photooxidation. J Heart Valve Dis. 6:(3):1997 May;307-315